FREDERICK, Md., March 20, 2014 /PRNewswire/
-- BioElectronics Corporation (OTC Pink: BIEL), the maker of
advanced consumer medical devices, announced today that the
Depository Trust Company has determined to end the deposit
transaction restriction (the Deposit Chill) it had previously
placed on shares of BioElectronics.
The Company said it was notified of the Depository Trust
Company's decision in a letter via email to James D. Pierce, Esq. of Sugarland, Texas has represented the corporation in this
matter. The letter from DTC counsel Donald Maj said that the DTC has "resumed
accepting deposits of the Issue for deposits and book entry
transfer services."
"We are pleased that the DTC has decided to remedy this
situation which has been an inconvenience and burden on our
shareholders," said Richard Staelin,
Chairman of the Board of BioElectronics Corporation and the Edward
and Rose Donnell Professor of Business Administration at The Fuqua
School of Business, Duke
University.
"We expect that our shareholders will soon see an improvement in
the trading environment as the news of this action is acted upon by
the brokerage community."
About BioElectronics Corporation
BioElectronics
Corporation is a leader in biophysics and the maker of an industry
leading family of disposable, drug-free, pain therapy devices:
ActiPatch® Therapy, over-the-counter treatment for back
pain and other musculoskeletal complaints; RecoveryRx®
Devices for chronic and post-operative wound care;
Allay® Menstrual Pain Therapy; and HealFast®
Therapy for dogs, cats and horses. For more information,
please visit www.bielcorp.com.
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation